Illumina, Inc. vs LTC Properties Inc — how do they compare? Illumina, Inc. trades at $268.5 (market cap $39.95B), while LTC Properties Inc trades at $43.29 (market cap $2.27B). The key difference: Illumina, Inc. is far larger — about 17.6× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.42% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and LTC Properties Inc for 89 Days on average.
| ILMN | LTC | |
|---|---|---|
Market Cap | $39.95B | $2.27B |
Volume | 3,169,503 | 574,171 |
Sector | Health | Real Estate |
52-Week High | $293.69 | $43.50 |
52-Week Low | $91.00 | $33.98 |
Typical Hold Time | 83 Days | 89 Days |
Enterprise Value | $41.31B | $3.01B |
Dividend Yield | — | 5.42% |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% today but remains near recent highs after a strong 94.9% YTD rally. The stock shows bullish technical momentum with recent earnings beats and improved profitability, with net income turning positive to $850 million in 2025 after previous losses. S&P 500 inclusion in September 2026 and growing AI integration in genomics provide positive catalysts, though valuation metrics remain elevated with a P/E of 49.36.
Outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI adoption, while risks include China headwinds, margin pressure, and high valuation multiples requiring sustained execution to justify premium pricing.
LTC Properties trades at $41.81, down 1.48% over the past day. The stock shows a mixed technical picture with a bullish moving average signal but neutral oscillators. Fundamentally, the company reported strong revenue growth to $262.85 million in 2025 and a net income margin of 38.93%, though earnings have been volatile with a recent miss in Q1 2026. Recent corporate actions include ongoing monthly dividends of $0.19 per share and strategic acquisitions to accelerate growth in seniors housing properties.
The outlook for LTC is cautiously optimistic, supported by demographic tailwinds in senior care and a consensus price target of $49.67 implying 19% upside. Key risks include rising interest rates impacting financing costs and execution challenges in transitioning its portfolio. Analyst sentiment is mixed with 32% buy ratings, highlighting balanced risk-reward near current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →